By Jeff Montgomery ( April 1, 2019, 8:19 PM EDT) -- With billions in the balance, Ligand Pharmaceuticals Inc. urged the Chancery Court Monday to toss a suit over a bungled formula description in an indenture for $250 million in notes, in a first-of-its-kind test of a deal term allowing an after-the-fact fix....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.